Latest News at the SOGC

SOGC Statement – Vaping and Pregnancy

The Society of Obstetricians and Gynaecologists of Canada (SOGC) is alarmed at the growing number of serious lung illnesses and deaths reported in young adults that have been attributed to vaping. E-cigarettes have been available for 15 years, however the reasons why serious complications are arising now is not fully understood and is under active investigation.

Nicotine is known to be harmful to the developing baby, and cigarette smoking, in particular affects the growth and development of the baby and the baby’s brain. Knowing this, many women have chosen e-cigarettes as a means to reduce nicotine exposure or quit smoking.  However, the safety of vaping has not been established in pregnancy. 

At present time women who are pregnant or who may become pregnant are advised to avoid use of e-cigarettes and to see their health care provider for assistance in quitting smoking. 

November 15, 2019
SOGC Statement – Vaping and Pregnancy

SOGC Statement – Oxytocin Update (November 15)

The SOGC has been in constant contact with Health Canada in relation to the Oxytocin shortage. In early November they updated stakeholders as to the status of the supply. These are the outcomes of that update.

  • Fresenius Kabi has received the resupply of approx. 190,000 vials of 1mL and expect to have the resupply available nationally by November 8. The estimated end date on Fresenius Kabi’s drug shortage report has been updated accordingly (
  • Pfizer released the resupply of 62,630 ampoules of 1mL on October 18. Additionally, Pfizer was able to expedite the next resupply of 100,790 ampoules of 1mL which was released to market on October 30.
  • Based on Pfizer’s and Fresenius’ current supply on hand and at wholesale, there are currently approximately 200,000mL available, which correlates to approx. 1.5 months of supply under normal conditions. Additional supply may exist at wholesale and in the health care system. If FK’s November 8 release occurs on time, the amount of supply available on the Canadian market would increase to approximately 3 months of supply under normal conditions.
  • In terms of future resupplies, Pfizer has indicated that another resupply of 1mL ampoules is expected later in November in addition to a resupply of 22,000 ampoules of 5mL. Fresenius has another resupply of 1mL vials that will be available in mid-December. It is Fresenius' intention to return to market at 100% allocation on November 8 for the 1mL, and a mix of 10mL and 1mL to cover their 10mL demand.

Health Canada will continue to monitor supply of Oxytocin, and the SOGC will continue to communicate updates as they become available.

November 15, 2019
SOGC Statement – Oxytocin Update (November 15)

Health Canada Advisory: PregVit and PregVit folic 5 

Health Canada Advisory: Duchesnay Inc. recalls certain lots of PregVit and PregVit folic 5 prenatal and postpartum vitamin-mineral supplements because of a packaging error

Health Canada is advising Canadians that Duchesnay Inc. is recalling certain lots of PregVit vitamin-mineral supplements (for prenatal and postpartum use) and PregVit folic 5 vitaminmineral supplements (for prenatal use) because blister packages may contain all pink (morning) tablets instead of the correct combination of pink and blue (evening) tablets. The company estimates the issue affects a very small number of products in certain lots (see the table below) and not all products.  

There are no quality, safety or effectiveness concerns with the tablets themselves but there is the potential that patients may not take the proper combination of pink and blue tablets if they have received products impacted by the packaging error.  

The pink and the blue tablets do not contain the same active ingredients. Women taking all pink tablets will not receive the intended vitamin and mineral supplements. In particular, the pink tablets do not contain folic acid, which is important for the healthy growth of an unborn baby and helps to reduce some types of birth defects called neural tube defects.  

Properly packaged products should contain two blister packs, with each blister pack containing 15 pink tablets and 15 blue tablets. The company received a complaint of a product containing a blister pack that contained all pink tablets and no blue tablets.  

Who is affected 
Women who have bought or are using the affected products. 

Affected products  
PregVit Format 60 
DIN: 02451573 

  • Lot: 19003 / Expiry: 2021-10-31
  • Lot: 19001V / Expiry: 2021-09-30
  • Lot: 18015V / Expiry: 2021-08-31
  • Lot: 18010V / Expiry: 2021-05-31
  • Lot: 18012V / Expiry: 2021-04-30
  • Lot: 18006V / Expiry: 2020-08-31
  • Lot: 18003V / Expiry: 2020-06-30
  • Lot: 17019V / Expiry: 2020-05-31
  • Lot: 17016 / Expiry: 2020-07-31
  • Lot: 17002 / Expiry: 2020-03-31
  • Lot: 16065 / Expiry: 2020-02-29
  • Lot: 16064 / Expiry: 2020-01-31
  • Lot: 16045 / Expiry:  2019-12-31
  • Lot: 16042 / Expiry: 2019-12-31

PregVit folic 5 Format 60 
DIN: 02451581
  • Lot: 18022 / Expiry: 2021-07-31
  • Lot: 18007 / Expiry: 2020-10-31 
  • Lot: 18002 / Expiry: 2020-09-30
  • Lot: 16053 / Expiry: 2019-12-31 

What consumers should do

  • Check your product to make sure it contains the correct combination of pink and blue tablets (each blister pack should contain 15 pink and 15 blue tablets [see photos]).  
  • Continue taking the prescribed number of pink and blue tablets per day as directed by your health care professional. If your product has an incorrect tablet combination, talk to your pharmacist about obtaining a replacement. Properly packaged products do not need to be returned.  
  • Consult your health care professional if you have used either of these products and have health concerns.  
  • Contact Duchesnay Inc. by calling toll-free at 1-888-666-0611, or by email at, if you have any questions about the recall.  
  • Report any health product adverse events or complaints to Health Canada. 

Additional information for pharmacists

  • Check packages of PregVit and PregVit folic 5 before dispensing them to patients.  
  • Not all lots are being recalled. While the company has put a verification process in place to make sure that products not impacted by this recall are properly packaged, checking products before dispensing provides an added safeguard.  

What Health Canada is doing 

Health Canada is monitoring the recall and verifying that the company has effectively addressed the packaging issue. Should additional safety concerns be identified, Health Canada will take appropriate action and inform Canadians as necessary. 

PregVit – box

PregVit – properly packaged blister pack

PregVit folic 5 – box 

PregVit folic 5 – properly packaged blister pack

Public Enquiries:
(613) 957-2991
1-866 225-0709
November 15, 2019
Health Canada Advisory: PregVit and PregVit folic 5

About the SOGC

The SOGC is one of Canada’s oldest national specialty organizations. Established in 1944, the Society’s mission is to promote excellence in the practice of obstetrics and gynaecology and to advance the health of women through leadership, advocacy, collaboration, and education.

The SOGC has over 4,000 members, comprised of obstetricians, gynaecologists, family physicians, nurses, midwives, and allied health professionals working in the field of sexual reproductive health.

Learn More Meet the Board Academic Council
Guidelines and JOGC

About the JOGC

The Journal of Obstetrics and Gynaecology Canada (JOGC) publishes original research, reviews, case reports, and commentaries by Canadian and international authors, pertinent to readers in Canada and around the world. The Journal covers a wide range of topics in obstetrics and gynaecology and women’s health covering all life stages including the evidence-based Clinical Practice Guidelines, Committee Opinions, and Policy Statements that derive from standing or ad hoc committees of The Society of Obstetricians and Gynaecologists of Canada.

The Journal emphasizes vigorous peer-review and accepts papers in English and French. Abstracts for all papers are available in both languages. JOGC is indexed in Medline.

Members - You MUST sign in below before proceeding to to access member-only content published in the JOGC.

Access to the JOGC is a benefit of SOGC membership.

Sign in to take advantage of this member benefit or join the SOGC to enjoy the Journal by clicking on ‘Become a Member’ below.

Latest SOGC Guidelines

Upcoming SOGC Guidelines

Video Corner

Dr. Bill Ehman on the SOGC's Newest Online Course: "Vaccination in Pregnancy"

"Should my pregnant patient get a flu shot?" "My patient has received a Tdap vaccine before - does she need another one in this pregnancy?" "How can I make a strong recommendation about vaccination to my vaccine-hesitant patients?"

We sat down with Dr. Bill Ehman to review these considerations. Find the answers to these questions and more in the SOGC’s newest online course : "Vaccination in Pregnancy". Registration will be available soon - keep checking our Online Courses page.


GRADE | EndNote

Online Courses
Premier medical education combined with the convenience of online study.

Online Courses

Designed by SOGC experts and employing the most current medical knowledge, our accredited online courses combine premier medical education with the convenience of online study. 

These courses are designed specifically for improving the learning experience and to tailor your educational experiences to meet your personal learning objectives.


Go to SOGC Online Platform

Already registered?

Please log in to access SOGC Online Platform.

ALARM Courses
Improving care provided to women, babies and families during pregnancy, labour and delivery.

ALARM Courses

The SOGC places the utmost importance on improving intrapartum care, from the process to its outcomes. One way to achieve that objective is through offering continuing education programs like the ALARM course (Advances in Labour and Risk Management).

Welcome and Overview

ALARM was developed by obstetricians/gynaecologists, family physicians, midwives and nurses, who jointly continue to maintain and teach the course. Backed by the SOGC, the ALARM course arose out of our work to improve the care provided to women, babies, and families during pregnancy, labour, and postpartum.

  • The content of the course is evidence-based and incorporates the Canadian practice guidelines, so participants who complete the course gain an understanding of the latest best practices for providing care.
  • The ALARM course objective is to evaluate, update and maintain the competence of obstetricians/gynaecologists, family physicians, midwifes and nurses.
  • This two-day course offers case-based and hands-on workshops.
  • This course is not intended to certify attendees in any procedural skills. It provides education and hands-on experience, but this is not a substitute for clinical exposure and mentorship.
  • The courses have a ratio of approximately 6 participants to 1 faculty member to ensure a highly interactive and educational course.
The ALARM certificate will be awarded only to those who pass the written examination and who attend the course in its entirety.

If you are unable to attend an ALARM course but would like to purchase an ALARM manual, please download this form and submit it by email to

Upcoming Courses

Please note that there are upcoming ALARM courses planned that are not yet listed below. They will be added as soon as logistical aspects are finalized.

If you would like to hold an ALARM course in your community, please contact us at Please note that a minimum of 12 participants is required.

Should you have any questions about your registration, please do not hesitate to contact us at

Instructor Courses - Overview

The ALARM program would not be possible without the efforts of specialists, physicians, nurses and midwives trained to teach this course to their peers. In order to maintain the quality of this highly recognized program, the ALARM Committee has identified specific requirements for instructors throughout Canada.

In order to be eligible to take the instructor course, you must:
  • Have participated in an ALARM course in the past 4 years
  • Be currently registered as an MD (Family Physician or OB/GYN), Registered Nurse or Registered Midwife
  • Be actively providing intrapartum obstetrical care

If you meet the above requirements and wish to participate in the ALARM instructor course, please submit an application at the link below. Please note, a letter of recommendation from your employer, department head or a current ALARM Course Director is required.

If you are selected, you will be sent a registration link for the course. At this point, you will be able to pay your registration fees ($650 plus applicable taxes for OB/GYN and FP doctors; $500 plus applicable taxes for Registered Nurses and Registered Midwives) and receive access to the course materials.

Your participation at the ALARM instructor course is not a guarantee that you will become a qualified ALARM Instructor. 

To become a qualified ALARM instructor, you must:
  • Complete the Instructor course
  • Teach a course
  • Receive a favourable evaluation from the Course Director

Please note you will be required to teach once every three years to maintain your status as an active instructor following a successful completion of the evaluation process. If you fail to do so, you will have to take another ALARM course or Instructor course to maintain your active instructor status.

Space is limited to 24 participants per course. 

There are currently no scheduled Instructor courses available. 

Become a Member

The SOGC is the leading voice in women's health in Canada. We are a strong and vibrant society with an active and growing membership. We are here to support you in providing the best care possible to women in Canada and around the world. That's why so many health care providers have become members of the SOGC. Let us be your partner in practice.

Join now

Upcoming events

March 12 - 14
West/Central CME 2020
Banff, Alberta

Public Education Resources

The SOGC believes that good healthcare is built upon many partnerships and that improving healthcare requires a collaborative, holistic approach.

Providing the public with the information needed to make informed health decisions removes one barrier to improved health.

Rated one of the top 5 e-health projects in the world, provides credible and up-to-date sexual health information for teens, adults, parents, teachers, and health care providers.


No content found

No content found

No content found

No content found

No content found

No content found


Brand Recognition Program

The SOGC Brand Recognition Program aims to assist Canadian consumers to make informed choices when selecting over-the-counter products. 

Learn More